Datasets:

Suchinthana
/

support2-1

Dataset card Data Studio Files Files and versions Community

Split (1)

train · 9.11k rows

ID int64 1 9.11k	age float64 18 102	death int64 0 1	sex stringclasses 2 values	hospdead int64 0 1	slos int64 3 343	d.time int64 3 2.03k	dzgroup stringclasses 8 values	dzclass stringclasses 4 values	num.co int64 0 9	edu float64 0 31 ⌀	income stringclasses 4 values	scoma float64 0 100 ⌀	charges float64 1.17k 1.44M ⌀	totcst float64 0 633k ⌀	totmcst float64 -102.72 711k ⌀	avtisst float64 1 83 ⌀	race stringclasses 5 values	sps float64 0.2 99.2 ⌀	aps float64 0 143 ⌀	surv2m float64 0 0.97 ⌀	surv6m float64 0 0.95 ⌀	hday int64 1 148	diabetes int64 0 1	dementia int64 0 1	ca stringclasses 3 values	prg2m float64 0 1 ⌀	prg6m float64 0 1 ⌀	dnr stringclasses 3 values	dnrday float64 -88 285 ⌀	meanbp float64 0 195 ⌀	wblc float64 0 200 ⌀	hrt float64 0 300 ⌀	resp float64 0 90 ⌀	temp float64 31.7 41.7 ⌀	pafi float64 12 890 ⌀	alb float64 0.4 29 ⌀	bili float64 0.1 63 ⌀	crea float64 0.1 21.5 ⌀	sod float64 110 181 ⌀	ph float64 6.83 7.77 ⌀	glucose float64 0 1.09k ⌀	bun float64 1 300 ⌀	urine float64 0 9k ⌀	adlp float64 0 7 ⌀	adls float64 0 7 ⌀	sfdm2 stringclasses 5 values	adlsc float64 0 7.07
901	35.52597	1	female	1	9	9	ARF/MOSF w/Sepsis	ARF/MOSF	3	14	under $11k	41	190,585	50,592.1562	53,178.5312	52	white	28.398438	44	0.584961	0.475952	12	0	0	yes	0.2	0.2	dnr after sadm	6	135	5	120	20	36.5	153.3125	null	null	0.799927	149	7.449219	399	26	1,770	null	0	<2 mo. follow-up	0
902	80.46295	0	male	0	5	1,025	CHF	COPD/CHF/Cirrhosis	2	16	>$50k	0	13,833	6,499.4727	7,339.70703	11	white	15.699219	9	0.861938	0.771973	1	0	0	no	0.93	0.75	no dnr	5	82	5.5	80	20	36.5	null	3.199707	0.799927	1.199951	142	null	91	26	2,500	1	1	no(M2 and SIP pres)	1
903	44.02499	1	male	0	6	8	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	55	35,099	14,571.9219	56,632.7188	38	white	29.597656	39	0.608887	0.50293	1	0	0	no	0.2	0.1	no dnr	6	75	11.199219	100	10	37.5	328.5625	2	35	1.199951	136	7.429688	106	19	3,520	null	6	<2 mo. follow-up	6
904	35.26599	0	male	0	11	1,023	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$11-$25k	0	48,956	23,854.9062	24,607.375	15	white	15	19	0.94397	0.922974	1	0	0	no	0.8	0.8	no dnr	11	66	13.099609	82	16	38.39844	245	2.799805	0.099991	0.799927	148	7.319336	110	4	2,870	6	6	SIP>=30	6
905	37.25098	1	male	1	3	3	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$11-$25k	55	83,192	13,650.0703	15,727.7344	40	white	54.796875	84	0.008999	0.001	21	0	0	no	0	0	dnr after sadm	2	42	12	85	24	38.79688	70	3.699707	37	5.599609	142	7.579102	110	49	0	null	null	<2 mo. follow-up	3.012207
906	62.133	1	male	1	13	13	CHF	COPD/CHF/Cirrhosis	4	12	>$50k	0	153,171	40,508.2812	48,524.2812	30	white	31	40	0.628906	0.444946	13	0	0	no	0.7	0.7	no dnr	13	47	11.5	80	20	36.79688	null	null	null	3	132	null	null	77	3,885	0	null	<2 mo. follow-up	0.494751
907	32.64099	1	female	1	35	35	MOSF w/Malig	ARF/MOSF	2	12	$11-$25k	0	358,494	126,852.438	118,579.5	25.25	white	27.097656	54	0.589966	0.481995	13	0	0	yes	0.85	0.5	dnr after sadm	34	107	0.099991	78	20	38	null	null	2	2.199707	137	null	307	70	3,475	0	0	<2 mo. follow-up	0
908	76.44098	1	male	0	9	220	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$25-$50k	0	23,486	11,454.5703	12,023.6094	9.5	white	25.5	37	0.612915	0.507935	1	1	0	metastatic	0.9	0.8	no dnr	9	78	21.296875	84	16	36	250	3	0.399963	5.5	131	7.40918	189	69	2,560	0	0	no(M2 and SIP pres)	0
909	77.59094	1	male	1	19	19	ARF/MOSF w/Sepsis	ARF/MOSF	3	8	under $11k	37	355,655	84,230.5625	111,434.375	56	white	30	62	0.337952	0.221985	28	0	0	no	0.1	0.1	dnr after sadm	3	57	18	115	32	38.5	224	null	1.799805	3.5	142	7.279297	137	73	1,035	null	null	<2 mo. follow-up	3.719238
910	51.09698	1	male	0	12	112	Lung Cancer	Cancer	2	16	null	0	37,350	17,216.1094	15,744.8359	26	white	27.097656	29	0.503906	0.18399	1	0	0	metastatic	1	1	no dnr	12	65	16.597656	135	36	37.5	200	null	null	0.899902	130	7.399414	126	9	2,547	null	0	null	0
911	95.70697	1	female	1	3	3	ARF/MOSF w/Sepsis	ARF/MOSF	2	14	>$50k	100	16,032	6,691.8477	65,455.625	5	white	27.5	87	0.115997	0.050995	1	0	1	no	null	null	dnr before sadm	-1	65	35.09375	115	40	36	374	null	null	1.699951	137	7.299805	395	44	20	null	null	<2 mo. follow-up	6.928711
912	78.18799	0	female	0	5	1,018	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	9	18,497	9,117.4766	8,865.25781	9	white	16.296875	7	0.844971	0.791992	1	0	1	no	0.9	0.9	no dnr	5	98	10	98	20	37	348.5625	null	null	1.099854	139	7.589844	114	8	1,650	null	null	null	4.931641
913	61.142	1	male	0	29	56	ARF/MOSF w/Sepsis	ARF/MOSF	2	22	$25-$50k	0	365,437	68,879	94,911.625	24.25	black	32	67	0.579956	0.469971	26	1	0	no	0.8	0.6	no dnr	29	118	10.199219	65	36	35.39844	167.5	3.399902	2.799805	6.299805	136	7.469727	281	101	0	null	2	<2 mo. follow-up	2
914	84.99695	1	male	0	6	9	Coma	Coma	2	null	null	100	19,473	8,654.4922	8,656.26562	9	white	16	23	0.156982	0.103989	1	0	0	yes	0.05	0	dnr after sadm	2	119	14	82	20	38.39844	487.5	null	null	1.399902	133	7.429688	170	20	850	null	null	<2 mo. follow-up	3.388672
915	84.37195	1	female	0	13	18	ARF/MOSF w/Sepsis	ARF/MOSF	0	10	null	37	64,321	23,580.1406	31,104.3281	24.5	white	26.199219	40	0.485962	0.367981	3	0	0	no	0.1	0.05	dnr after sadm	3	58	13.699219	145	12	39.39844	371.375	2.5	0.5	0.799927	129	7.319336	157	30	3,125	null	3	<2 mo. follow-up	3
916	77.99298	1	male	1	4	4	CHF	COPD/CHF/Cirrhosis	0	21	$25-$50k	26	90,070	10,376.7812	13,071.2656	37	black	30.296875	67	0.383972	0.188995	27	0	0	no	null	null	dnr after sadm	3	53	21.199219	65	28	37.59375	246.65625	null	0.799927	2.599609	129	7.289062	108	73	162	null	null	<2 mo. follow-up	2.666504
917	79.97797	1	male	1	11	11	ARF/MOSF w/Sepsis	ARF/MOSF	3	10	$11-$25k	55	121,331	38,597.4688	44,131.0938	42	white	31.5	49	0.243988	0.140991	5	0	0	no	0.1	0.05	dnr after sadm	11	58	9.298828	70	12	38.19531	127.5	null	2.199707	4.599609	129	7.40918	97	87	2,631	null	6	<2 mo. follow-up	6
918	79.06396	1	male	1	11	11	ARF/MOSF w/Sepsis	ARF/MOSF	0	16	$25-$50k	37	107,076	39,846.7812	48,046.5625	43.5	white	34	80	0.312988	0.199982	2	0	0	no	0.2	0.2	dnr after sadm	11	58	26.296875	165	22	38	73	2.199707	0.899902	1.799805	145	7.449219	189	38	1,559	null	0	<2 mo. follow-up	0
919	45.043	1	male	1	3	3	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	under $11k	55	30,354	12,436.8125	16,955.6875	29	white	85.1875	104	0	0	1	0	0	no	0.1	0.05	dnr after sadm	2	5	14.5	0	5	38.79688	120	3.299805	1.799805	4.399414	124	7.719727	100	92	275	null	null	<2 mo. follow-up	1.614258
920	50.155	1	male	0	27	489	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	>$50k	0	372,270	82,504.6875	95,984.4375	28.5	white	26.597656	40	0.756958	0.679932	20	0	0	no	0.8	0.7	no dnr	27	113	13.599609	110	6	38.29688	267.5	2.799805	4.199219	2.699707	137	7.419922	330	111	3,826	null	0	adl>=4 (>=5 if sur)	0
921	56.211	0	female	0	24	1,011	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$11-$25k	0	135,949	51,641.1562	56,310.7812	35	white	24.898438	38	0.793945	0.726929	4	0	0	no	0.7	0.7	no dnr	24	65	11.5	45	14	38.5	270	2.899902	1.099854	3.699707	139	7.459961	89	32	1,965	null	5	adl>=4 (>=5 if sur)	5
922	51.18698	1	female	0	6	17	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	0	56,973	10,217.1094	14,171.0625	12	white	31.898438	27	0.532959	0.417969	6	0	0	metastatic	0	0	dnr before sadm	-3	75	13.798828	126	16	36.69531	114.28125	null	null	1.599854	132	7.389648	164	13	3,150	null	null	<2 mo. follow-up	2.859863
923	47.95099	1	male	0	10	77	MOSF w/Malig	ARF/MOSF	3	18	$11-$25k	0	53,439	16,939.0469	18,911.2344	23.5	hispanic	24.199219	51	0.615967	0.510986	3	0	0	metastatic	0.15	0.05	dnr after sadm	4	98	12.5	110	36	39.39844	419	1.799805	null	1.599854	134	7.369141	157	25	1,450	null	0	adl>=4 (>=5 if sur)	0
924	100.24597	1	male	1	3	3	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	100	51,328	17,097.4062	21,092.9688	50	white	69.5	111	0	0	1	0	0	no	0	0	dnr after sadm	3	22	15.599609	130	26	36.5	56	2.299805	12.898438	2.299805	145	7.359375	49	18	0	null	null	<2 mo. follow-up	4.179688
925	75.95294	1	male	1	4	4	Coma	Coma	1	17	$11-$25k	100	13,525	6,125.9453	7,656.14844	7	white	24.898438	37	0.051994	0.026997	1	0	0	yes	null	null	dnr after sadm	2	100	100	76	28	40.69531	211	null	null	1.799805	135	7.40918	179	32	1,600	null	null	<2 mo. follow-up	3.084961
926	36.39398	1	male	1	64	64	ARF/MOSF w/Sepsis	ARF/MOSF	4	12	under $11k	0	492,853	180,981.875	200,351.25	28.25	black	22.898438	39	0.86499	0.817993	8	0	0	no	null	null	no dnr	64	65	9.298828	115	26	36.79688	null	null	null	1.5	150	null	153	38	1,467	null	5	null	5
927	76.21399	0	female	0	7	1,003	COPD	COPD/CHF/Cirrhosis	2	14	under $11k	0	30,490	8,519.5	8,446.625	9	white	30.597656	47	0.577881	0.383972	2	0	0	no	null	null	no dnr	7	107	11.199219	110	12	36.39844	65	null	0.199982	1.199951	143	7.299805	132	25	1,600	2	3	no(M2 and SIP pres)	3
928	87.05798	1	female	0	40	956	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	null	26	202,508	71,926.125	76,031	26.5	white	27.796875	43	0.233978	0.133972	15	0	0	metastatic	0.85	0.85	no dnr	40	72	18.597656	115	26	37.89844	206.09375	null	null	2	131	7.5	156	55	2,990	null	5	adl>=4 (>=5 if sur)	5
929	80.10095	1	female	0	37	47	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	$25-$50k	44	299,289	109,288.875	135,325.125	43	white	29.199219	41	0.277954	0.168976	5	0	0	yes	0.7	0.7	no dnr	37	132	12.798828	115	28	36.79688	117.14062	2.5	0.599976	0.699951	136	7.399414	152	19	4,355	null	0	<2 mo. follow-up	0
930	62.724	1	female	1	15	15	Coma	Coma	1	18	$11-$25k	61	109,193	45,729.5938	171,166.25	35.666657	white	22	21	0.487976	0.415955	1	0	0	no	0	0	dnr after sadm	13	130	10.5	65	15	38.39844	146	3.699707	0.799927	0.599976	133	7.489258	150	5	2,495	null	null	<2 mo. follow-up	2.427246
931	81.50897	0	male	0	7	1,000	CHF	COPD/CHF/Cirrhosis	5	12	under $11k	0	13,004	7,194.4648	8,583.49219	9	white	19.699219	31	0.81189	0.694946	1	1	1	no	0.8	0.4	no dnr	7	111	6.199219	80	26	36	null	null	null	1.899902	140	null	null	33	950	null	4	adl>=4 (>=5 if sur)	4
932	32.08499	1	male	0	34	877	CHF	COPD/CHF/Cirrhosis	3	12	null	0	162,263	71,892.875	85,921.5625	29.25	hispanic	20.796875	31	0.925903	0.875	1	0	0	no	0.5	0.25	no dnr	34	53	5.599609	105	16	36.5	null	3.899902	1.099854	1.299805	134	null	103	27	4,955	2	5	no(M2 and SIP pres)	5
933	71.85498	1	male	1	7	7	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	26	95,439	26,086.2969	33,033.1875	42	asian	42.796875	65	0.135986	0.062988	5	0	0	no	0.1	0.05	dnr after sadm	7	55	11.599609	105	32	36.5	134	2.399902	1.599854	4.299805	125	7.419922	null	71	2,795	null	0	<2 mo. follow-up	0
934	90.20697	1	female	0	4	476	ARF/MOSF w/Sepsis	ARF/MOSF	1	9	$11-$25k	0	12,549	5,989.2891	5,923.54688	11	white	26.296875	48	0.657959	0.559937	1	0	0	no	null	null	no dnr	4	75	8.298828	70	22	35.89844	134.6875	null	null	2.699707	137	7.25	390	38	600	0	null	null	0.494751
935	67.92896	1	female	0	15	129	CHF	COPD/CHF/Cirrhosis	0	8	under $11k	0	82,258	36,620.5312	43,184.7812	26	hispanic	19.796875	23	0.85498	0.760986	1	0	0	no	0.5	0.5	dnr after sadm	5	57	7.099609	55	22	36.29688	null	null	null	0.899902	134	null	140	15	1,890	1	null	SIP>=30	1.166748
936	35.76498	0	female	0	14	996	ARF/MOSF w/Sepsis	ARF/MOSF	4	13	$25-$50k	0	94,457	38,957.1562	45,480.5938	27.333328	white	28.597656	30	0.837891	0.782959	1	0	0	no	0.6	0.7	no dnr	14	130	16	120	20	39	114.28125	2.599609	0.5	0.599976	136	7.40918	104	11	3,540	null	5	no(M2 and SIP pres)	5
937	73.75494	1	female	1	28	28	Coma	Coma	1	12	under $11k	89	334,890	101,755.062	117,419.125	38.25	hispanic	23.898438	62	0.047997	0.023998	18	0	0	yes	0.09	0.000729	dnr after sadm	12	125	0.049995	125	40	38.89844	260	2.199707	1.899902	0.799927	152	7.509766	314	17	4,755	null	5	<2 mo. follow-up	5
938	54.004	0	female	0	58	991	ARF/MOSF w/Sepsis	ARF/MOSF	4	12	$25-$50k	37	748,973	null	null	46	white	48.5	84	0.049995	0.015999	17	1	0	no	0.1	0.1	no dnr	58	45	0.199982	105	32	36.89844	202	3.299805	4.5	3.599609	142	7.359375	163	95	525	null	1	adl>=4 (>=5 if sur)	1
939	52.51199	0	female	0	15	990	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	>$50k	0	69,096	19,972.7031	18,123.1094	10	white	21	27	0.814941	0.75293	5	0	0	yes	0.99	0.98	no dnr	15	88	13.398438	142	20	38.19531	256.625	1.399902	null	0.699951	136	7.359375	113	5	3,400	0	3	no(M2 and SIP pres)	3
940	38.168	0	female	0	23	990	ARF/MOSF w/Sepsis	ARF/MOSF	1	20	$25-$50k	44	151,909	61,569.8125	71,126.6875	31.666656	hispanic	30.898438	63	0.656982	0.55896	1	0	0	no	0.5	0.5	no dnr	23	102	27.199219	140	26	38.09375	146.65625	2	0.799927	1.899902	151	7.259766	131	21	2,665	null	null	SIP>=30	2.968262
941	49.02399	1	female	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	4	12	$25-$50k	0	64,403	22,841.6094	28,431.3281	55	white	49	77	0.273987	0.165985	2	0	0	no	0.2	0.1	dnr after sadm	5	55	26.699219	105	10	35.5	186	3.299805	48.5	3	139	7.279297	164	83	645	null	0	<2 mo. follow-up	0
942	47.96198	0	male	0	7	988	COPD	COPD/CHF/Cirrhosis	1	14	under $11k	0	39,258	16,408.9688	17,686.3594	20.5	white	29.699219	38	0.837891	0.734985	1	0	0	no	0.95	0.98	no dnr	7	112	19.296875	135	40	37.89844	134.03125	3.399902	0.799927	0.799927	136	7.40918	null	25	3,950	1	null	null	1.166748
943	22.91299	0	male	0	25	987	ARF/MOSF w/Sepsis	ARF/MOSF	0	13	null	0	59,999	30,400.7031	29,596.125	18	black	18.898438	29	0.938965	0.916992	1	0	0	no	0.9	0.98	no dnr	25	65	11.099609	114	24	37.59375	null	2.599609	0.899902	1.099854	141	null	156	35	1,330	null	7	adl>=4 (>=5 if sur)	7
944	68.53894	0	male	0	29	985	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	26	246,417	58,176.3125	175,344.5	25.25	black	18.699219	8	0.804932	0.740967	1	1	0	no	null	null	no dnr	29	87	8.599609	115	6	38.69531	270	null	null	0.799927	149	7.449219	166	13	2,675	null	null	null	2.462402
945	94.80096	1	female	0	5	57	Lung Cancer	Cancer	1	null	null	44	11,088	5,479.2695	5,763.35938	16	white	21.597656	36	0.284973	0.044998	1	0	0	metastatic	0.25	0.05	no dnr	5	65	15.5	78	28	35.39844	null	null	null	0.799927	133	null	108	28	700	null	null	<2 mo. follow-up	4.578125
946	47.88498	1	female	0	19	887	ARF/MOSF w/Sepsis	ARF/MOSF	3	null	null	26	165,774	35,300.3125	36,197.8125	33	black	27.699219	49	0.60791	0.501953	8	1	0	yes	null	null	no dnr	19	52	9.599609	125	28	38.09375	175	2.199707	null	1.099854	144	7.419922	290	26	2,761	null	null	null	3.193359
947	52.98599	1	male	0	8	494	CHF	COPD/CHF/Cirrhosis	2	12	null	0	24,044	11,732.8672	12,113.2734	16	white	19.699219	23	0.894897	0.823975	1	0	0	no	0.9	0.8	no dnr	8	68	7.699219	115	28	39.09375	null	null	0.699951	1.299805	136	null	null	12	3,960	0	1	no(M2 and SIP pres)	1
948	41.26199	0	male	0	40	982	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	>$50k	0	346,799	97,818.8125	128,462.438	31	white	29.699219	70	0.763916	0.688965	6	0	0	no	0.8	0.8	no dnr	40	63	13.199219	170	40	38.5	192	2.5	6.399414	1	141	7.5	252	30	2,010	null	1	no(M2 and SIP pres)	1
949	60.96899	0	male	0	14	982	ARF/MOSF w/Sepsis	ARF/MOSF	3	10	$11-$25k	9	156,906	81,478.125	75,389.9375	32.666657	white	32.296875	36	0.643921	0.542969	1	0	0	no	0.6	0.4	no dnr	14	47	14.699219	105	30	37.69531	158.3125	null	1	1.299805	141	7.539062	97	27	4,730	null	5	no(M2 and SIP pres)	5
950	71.84698	0	male	0	30	980	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	37	210,555	78,092.875	88,523.125	37.25	white	69.890625	78	0	0	4	1	0	no	0.2	0.2	no dnr	30	0	6.299805	0	12	38.59375	345	2.5	0.699951	4.899414	133	7.399414	476	84	1,941	null	null	null	2.04541
951	84.31799	1	male	0	51	303	ARF/MOSF w/Sepsis	ARF/MOSF	1	18	>$50k	0	462,018	154,909.25	152,019.375	32.75	asian	20	34	0.797974	0.730957	1	0	0	no	0.6	0.5	dnr after sadm	45	63	9.699219	55	18	36.09375	191.40625	2.299805	null	1.199951	137	7.259766	null	29	1,870	null	null	null	2.802246
952	38.21799	1	female	1	6	6	Coma	Coma	3	14	>$50k	26	97,521	18,105.5781	19,183.1562	34	white	44.195313	75	0.093994	0.056	21	0	0	yes	0.75	0.7	dnr after sadm	4	118	15.898438	126	44	37.79688	160	2.199707	26.398438	1.899902	127	7.40918	null	24	3,275	null	5	<2 mo. follow-up	5
953	79.15698	1	female	1	4	4	Coma	Coma	2	15	$25-$50k	100	16,231	7,312.875	8,866.6875	27	white	45.5	64	0	0	1	0	0	yes	0.02	0.02	dnr after sadm	3	32	19.097656	195	10	35.79688	266.625	null	null	2.099609	145	7.569336	273	19	1,628	null	null	<2 mo. follow-up	3.667969
954	33.59097	0	male	0	10	979	ARF/MOSF w/Sepsis	ARF/MOSF	2	16	$25-$50k	0	81,881	19,257.6094	25,287.2656	12	hispanic	36.796875	40	0.630981	0.528931	17	0	0	no	0.9	0.8	no dnr	10	81	2.099609	95	16	37.59375	40	null	0.699951	2.299805	138	7.549805	120	38	2,096	2	null	no(M2 and SIP pres)	1.838867
955	73.61798	1	male	1	21	21	MOSF w/Malig	ARF/MOSF	1	16	>$50k	41	86,043	39,136.6875	44,971.0312	22.666656	white	19.199219	29	0.557983	0.445984	1	0	0	metastatic	0.5	0	dnr after sadm	5	62	5.599609	64	24	36	247.59375	2.099609	0.699951	0.799927	134	7.509766	215	15	2,410	null	5	<2 mo. follow-up	5
956	98.08899	1	female	1	4	4	Coma	Coma	1	16	under $11k	100	16,613	7,248.9062	9,300.8125	25	white	26.898438	16	0.006	0.002	1	0	1	no	0.15	0.15	dnr after sadm	1	82	10	135	24	36	190	null	null	0.399963	139	7.549805	155	5	2,525	null	null	<2 mo. follow-up	6.363281
957	65.09497	0	female	0	39	972	ARF/MOSF w/Sepsis	ARF/MOSF	0	18	null	26	358,169	103,605.875	127,812.75	39.25	white	20.597656	12	0.7229	0.636963	15	0	0	no	0.6	0.6	no dnr	39	103	11.099609	105	10	39.39844	240	3.799805	null	0.699951	136	7.539062	152	12	4,090	null	0	adl>=4 (>=5 if sur)	0
958	67.39197	1	female	0	26	30	ARF/MOSF w/Sepsis	ARF/MOSF	1	9	$11-$25k	41	213,912	49,587.5625	56,700.8438	21.25	black	29.597656	70	0.403992	0.283997	25	0	0	no	0.2	0.2	dnr after sadm	6	142	30	135	40	38.89844	576.625	2.399902	1	3	143	7.239258	286	62	5,785	null	0	<2 mo. follow-up	0
959	69.77698	0	male	0	11	972	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	37	88,609	21,318.4688	41,960.2812	44.5	white	21.597656	22	0.599976	0.491943	5	0	0	yes	null	null	no dnr	11	68	6	55	8	39.5	165.4375	null	null	1	136	7.459961	167	17	5,420	null	null	null	2.916016
960	77.20496	1	female	0	4	310	COPD	COPD/CHF/Cirrhosis	4	null	null	9	14,068	6,384.2812	6,269.42969	25	white	23.296875	46	0.718994	0.56189	1	0	0	no	0.9	0.8	no dnr	4	136	24.097656	150	24	36.39844	553	null	null	1	134	7.199219	89	27	790	null	null	null	3.659668
961	68.40796	0	female	0	8	971	COPD	COPD/CHF/Cirrhosis	6	null	null	0	19,252	10,880.3203	9,049.42969	11	white	16.296875	40	0.885986	0.809937	1	0	0	no	0.8	0.75	no dnr	8	75	4.299805	60	28	36.59375	339.125	null	0.599976	1.099854	141	7.369141	89	21	300	null	null	null	4.496094
962	74.25098	1	male	0	34	37	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	null	44	205,063	90,528.0625	119,766.75	39	white	41.796875	71	0.129974	0.058998	1	0	0	no	0.2	0.15	dnr after sadm	27	52	12	155	10	39.59375	280	2.5	10.099609	3.299805	153	7.459961	93	100	7,365	null	3	<2 mo. follow-up	3
963	35.92599	1	male	1	36	36	MOSF w/Malig	ARF/MOSF	2	12	$25-$50k	37	389,403	134,131.375	145,548.125	33	white	42.59375	79	0.034996	0.009998	23	0	0	yes	0.7	0.7	dnr after sadm	36	48	2	115	32	39.09375	246.9375	2	2.399902	4.199219	148	7.459961	null	101	210	null	0	<2 mo. follow-up	0
964	61.952	1	male	0	51	271	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	41	451,954	125,566.688	130,626.312	37	white	34.59375	57	0.292969	0.182983	25	0	0	no	0.2	0.2	no dnr	51	65	32.695313	115	37	39.09375	136.65625	null	null	5	143	7.469727	181	150	3,060	null	null	Coma or Intub	3.023438
965	75.87695	0	male	0	9	969	ARF/MOSF w/Sepsis	ARF/MOSF	1	19	>$50k	0	39,709	17,396.3906	20,330.3906	32	white	15.798828	25	0.872925	0.828979	1	0	0	no	0.6	0.3	no dnr	9	68	7.399414	95	8	37.69531	243.3125	null	null	1.299805	133	7.549805	null	25	4,468	null	null	no(M2 and SIP pres)	2.226563
966	50.034	1	female	1	5	5	MOSF w/Malig	ARF/MOSF	3	null	null	44	60,562	25,240.4688	31,265.9531	48	white	38.398438	54	0.133972	0.061996	1	0	0	yes	0.2	0.2	dnr after sadm	5	112	2.299805	125	26	39	140.8125	null	3.199707	2.299805	143	7.289062	166	36	6,295	null	null	<2 mo. follow-up	3.310547
967	66.90796	1	female	0	30	53	ARF/MOSF w/Sepsis	ARF/MOSF	2	15	null	9	137,219	57,231.9688	58,649.5	21.75	white	26.398438	24	0.565918	0.454956	3	0	0	metastatic	0.5	0.3	dnr after sadm	1	79	6.399414	110	24	36.39844	138.75	null	null	1	132	7.509766	168	10	2,620	null	5	<2 mo. follow-up	5
968	38.94299	1	female	1	16	16	Cirrhosis	COPD/CHF/Cirrhosis	5	12	under $11k	94	283,724	59,525.1562	61,740.7188	39	asian	46.695313	70	0.003	0	22	0	0	no	0.1	0.05	no dnr	16	118	null	115	34	36.5	178	null	50.09375	3.199707	151	7.579102	261	65	1,200	null	0	<2 mo. follow-up	0
969	32.07397	0	female	0	99	965	ARF/MOSF w/Sepsis	ARF/MOSF	5	null	null	41	793,804	343,271	403,864.75	48.5	hispanic	47.898438	90	0.241974	0.139984	1	1	0	no	0.7	0.7	no dnr	99	62	2.5	130	35	33.69531	323	2.399902	21.5	0.399963	148	7.399414	296	33	2,530	null	0	Coma or Intub	0
970	57.75198	0	female	0	4	964	CHF	COPD/CHF/Cirrhosis	1	11	under $11k	0	10,350	5,801.6016	7,100.69922	12	black	19.898438	37	0.881958	0.802979	1	0	0	no	null	null	no dnr	4	78	3.699707	65	28	36.29688	null	null	null	1.899902	139	null	97	66	1,350	1	1	SIP>=30	1
971	48.435	1	male	0	10	507	Colon Cancer	Cancer	1	null	null	0	18,298	9,905.8672	11,453.9375	18	white	14.099609	11	0.875977	0.719971	1	0	0	metastatic	0.7	0.6	no dnr	10	75	3.399902	70	20	36.39844	null	null	0.5	1	142	null	0	13	3,700	null	null	null	2.516113
972	56.50897	1	male	1	4	4	Coma	Coma	1	12	$11-$25k	55	25,303	9,744.8516	12,309.6562	33	white	17.5	33	0.612915	0.549927	1	0	0	yes	0.1	0	dnr after sadm	2	70	7.199219	65	37	38.19531	203.3125	2.899902	0.699951	1.299805	148	7.639648	126	30	3,155	null	null	<2 mo. follow-up	2.162598
973	48.47098	1	female	0	15	22	Lung Cancer	Cancer	1	17	under $11k	0	41,422	21,064.2656	117,872.188	15.333328	white	22.296875	19	0.634888	0.324951	1	0	0	metastatic	0.5	0.2	dnr after sadm	1	69	12.798828	112	24	36.19531	366.625	3.399902	0.199982	0.699951	136	7.469727	184	9	2,800	1	0	<2 mo. follow-up	0
974	23.24199	1	female	1	6	6	MOSF w/Malig	ARF/MOSF	2	16	under $11k	26	636,743	32,527.1719	31,102.0312	47	white	41.398438	53	0.077988	0.028999	85	0	0	yes	0	0	dnr after sadm	4	142	2.099609	65	14	38.39844	220	null	47.796875	3	141	7.389648	null	115	3,750	null	null	<2 mo. follow-up	2.65625
975	84.91394	1	male	0	16	33	CHF	COPD/CHF/Cirrhosis	5	16	null	0	42,792	22,130.0781	18,817.1719	15	white	18.898438	42	0.763916	0.625977	1	0	0	yes	0.5	0.25	no dnr	16	73	10.298828	74	22	36	204.75	null	null	1.5	137	7.469727	135	36	1,000	6	2	<2 mo. follow-up	2
976	57.28998	1	male	1	19	19	MOSF w/Malig	ARF/MOSF	2	14	>$50k	37	433,153	87,692.1875	104,910.438	37.333313	white	31.699219	47	0.199982	0.107986	46	0	0	yes	0.6	0.2	dnr after sadm	19	142	1.799805	130	36	36	297.125	null	2	0.799927	138	7.429688	186	34	4,203	null	0	<2 mo. follow-up	0
977	62.741	0	male	0	6	958	Cirrhosis	COPD/CHF/Cirrhosis	3	12	$11-$25k	0	17,289	10,762.1641	7,685.82812	11	hispanic	21.796875	45	0.743896	0.5979	1	0	0	no	0.9	0.8	no dnr	6	63	9.199219	64	12	36	null	2.199707	3.799805	0.899902	133	null	null	23	1,150	1	null	no(M2 and SIP pres)	1.166748
978	73.91595	1	female	0	19	68	Colon Cancer	Cancer	2	12	under $11k	0	37,120	19,875.8594	20,751.3281	11.333328	white	39	40	0.265991	0.037994	1	1	0	metastatic	0.3	0.1	no dnr	19	73	8.398438	118	30	38.39844	null	2	2.199707	0.699951	133	null	139	12	1,410	null	5	null	5
979	62.34598	1	male	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	3	14	$25-$50k	26	54,050	23,091.9219	26,999.375	53	white	35.398438	54	0.475952	0.357971	1	0	0	no	0.6	0.6	no dnr	5	45	24.398438	75	27	39.79688	115	2	1.799805	1.199951	146	7.55957	145	56	2,540	null	0	<2 mo. follow-up	0
980	19.765	1	male	1	6	6	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	0	null	21,340.4375	97,894.9375	49	hispanic	35.09375	69	0.738892	0.657959	14	0	0	no	0.25	0.25	no dnr	6	45	18.796875	145	40	38.39844	402.8125	null	null	1.699951	135	7.369141	302	71	1,707	null	null	<2 mo. follow-up	2.135742
981	62.965	1	male	0	11	224	CHF	COPD/CHF/Cirrhosis	4	null	null	0	32,473	15,833.9297	15,820.7969	23.5	white	21	32	0.856934	0.763916	1	0	0	no	0.95	0.95	no dnr	11	115	8.5	75	20	36	null	null	0.199982	4.699219	139	null	104	50	1,175	null	null	null	3.517578
982	51.98398	1	male	0	10	656	Colon Cancer	Cancer	1	14	>$50k	0	30,678	13,849.9844	22,026.2812	18.5	white	16.796875	25	0.841919	0.651978	1	0	0	metastatic	0.9	0.09	no dnr	10	110	6.799805	105	10	38.39844	null	null	0.5	1.199951	140	null	169	null	740	0	0	null	0
983	78.62	1	female	0	9	249	Lung Cancer	Cancer	1	null	null	0	20,276	10,465.7656	10,816.3672	10.5	white	23.199219	39	0.522949	0.200989	1	0	0	metastatic	0.5	0.15	dnr after sadm	2	77	14	68	26	36.59375	323.75	null	null	1.299805	126	7.579102	100	20	600	1	null	null	1.166748
984	46.51898	1	female	1	9	9	Coma	Coma	1	null	null	100	79,492	27,622.1875	31,629.6406	33	black	33.796875	63	0.039993	0.019997	5	0	0	yes	null	null	dnr after sadm	9	122	19.097656	125	27	38.59375	205	null	null	5	127	7.30957	88	49	3,620	null	null	<2 mo. follow-up	3.140625
985	60.16699	1	male	1	10	10	MOSF w/Malig	ARF/MOSF	2	null	null	0	142,620	47,904.9375	56,030.5	57	white	40.898438	83	0.192993	0.10199	4	0	0	yes	0.5	0.25	dnr after sadm	9	48	0.399963	175	25	39.79688	301.375	1.799805	0.299988	0.299988	143	7.489258	154	9	2,310	null	2	<2 mo. follow-up	2
986	33.01297	1	female	1	4	4	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$25-$50k	55	null	17,329.5156	18,879.5781	31	white	43.59375	81	0.161987	0.079987	38	0	0	no	null	null	dnr after sadm	4	117	4	120	54	38.5	490	2	28.5	2.599609	153	7.429688	256	115	2,500	null	null	<2 mo. follow-up	3.282227
987	53.71899	1	male	1	73	73	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	$25-$50k	9	651,870	204,370.375	204,853.625	30.5	white	33.796875	58	0.556885	0.44397	12	0	0	no	0.8	0.8	no dnr	73	45	13.898438	105	10	38.29688	402.5	null	null	5.399414	135	7.5	235	77	2	null	0	adl>=4 (>=5 if sur)	0
988	38.87698	1	male	0	60	135	ARF/MOSF w/Sepsis	ARF/MOSF	4	12	null	0	282,625	null	null	26.5	white	28.5	41	0.777954	0.705933	12	0	0	no	0.5	0.5	no dnr	60	112	12.298828	125	14	38.19531	155	null	0.899902	2.299805	142	7.509766	291	null	1,405	null	null	SIP>=30	3.08252
989	61.689	1	male	0	9	153	Colon Cancer	Cancer	1	null	null	0	16,468	9,625.2031	11,541.1641	21.5	white	12.398438	6	0.873901	0.716919	1	0	0	metastatic	null	null	no dnr	9	83	6.099609	80	22	38.29688	null	null	null	1	135	null	null	16	4,520	null	null	null	2.433106
990	69.125	0	female	0	8	942	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	0	64,500	9,428.2891	25,010.8594	17	white	28.796875	34	0.645996	0.545898	7	0	0	no	0.98	0.95	no dnr	8	105	10.699219	120	28	36	134.6875	null	0.199982	0.799927	140	7.40918	null	null	540	0	2	no(M2 and SIP pres)	2
991	30.98399	0	female	0	19	941	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	37	175,051	75,655.5	77,528.0625	33.666657	white	31.597656	33	0.685913	0.593994	2	0	0	no	0.8	0.7	no dnr	19	115	6.099609	45	18	39.39844	43	null	2.099609	1.099854	144	7.449219	127	17	2,915	null	null	null	2.61377
992	62.75998	0	female	0	107	941	ARF/MOSF w/Sepsis	ARF/MOSF	4	16	null	44	985,215	271,083	259,698.125	38	white	33.796875	67	0.282959	0.173981	58	1	0	no	0.5	0.4	no dnr	107	112	6.099609	125	28	36.5	305	3.899902	6	2.899902	146	7.509766	349	59	0	null	0	null	0
993	62.28897	1	male	0	9	532	Colon Cancer	Cancer	1	12	under $11k	0	34,721	16,882.9219	19,613.2344	14.5	white	13.298828	13	0.86499	0.697998	1	0	0	metastatic	1	1	no dnr	9	63	null	62	20	38.39844	null	null	null	null	140	null	null	null	1,900	null	0	null	0
994	38.94299	1	male	0	12	75	ARF/MOSF w/Sepsis	ARF/MOSF	0	14	>$50k	0	147,307	34,028.1875	83,803.0625	32	white	30	62	0.744995	0.665894	17	0	0	no	0.9	0.9	no dnr	12	108	17.699219	115	28	36	304	1.899902	8.898438	1.199951	135	7.399414	330	22	1,360	null	5	adl>=4 (>=5 if sur)	5
995	53.314	0	female	0	71	937	ARF/MOSF w/Sepsis	ARF/MOSF	2	14	$25-$50k	37	517,087	149,585.125	140,814.375	41	asian	27.597656	39	0.594971	0.487	11	0	0	no	0.5	0.3	no dnr	71	60	22.898438	105	26	38.79688	257.5	2.899902	16	1.099854	137	7.479492	228	19	3,079	null	null	SIP>=30	3.120117
996	67.63898	1	male	0	9	111	Lung Cancer	Cancer	1	12	under $11k	0	21,057	11,093.6875	12,304.8438	13.5	white	15	9	0.73999	0.474976	1	0	0	metastatic	0.8	0.5	no dnr	9	103	9.5	76	22	36.39844	null	null	null	1.099854	135	null	null	12	2,595	0	0	SIP>=30	0
997	57.34698	0	male	0	16	937	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$11-$25k	0	139,549	58,391.7188	66,013.8125	34.666657	hispanic	30.5	54	0.731934	0.648926	1	1	0	no	0.6	0.6	no dnr	16	55	14.398438	120	36	37	140	2.699707	0.399963	1	136	7.399414	508	23	4,170	null	6	no(M2 and SIP pres)	6
998	40.14798	0	male	0	14	935	ARF/MOSF w/Sepsis	ARF/MOSF	4	16	$11-$25k	0	172,266	25,485.3281	36,137	17.333328	white	20.796875	33	0.879883	0.837891	6	0	0	no	null	null	no dnr	14	123	8.599609	115	24	37	222.5	3.099609	3.599609	0.899902	145	7.449219	154	61	3,550	0	0	no(M2 and SIP pres)	0
999	60.37	1	female	0	6	443	Colon Cancer	Cancer	1	12	>$50k	0	8,439	4,481.9922	4,730.26953	8	white	13.798828	11	0.861938	0.691895	1	0	0	metastatic	0.8	0.5	no dnr	6	73	10	80	20	38.5	null	null	0.399963	0.699951	136	null	99	6	3,550	0	0	no(M2 and SIP pres)	0
1,000	22.741	0	male	0	20	934	Coma	Coma	0	17	$25-$50k	0	150,904	61,721.625	70,461.8125	44	hispanic	35.695313	54	0.746948	0.699951	1	0	0	no	0.3	0.3	no dnr	20	115	17.699219	125	20	39	61	2.399902	3.099609	1.799805	145	7.549805	93	32	3,290	null	0	no(M2 and SIP pres)	0

Subsets and Splits

No community queries yet

The top public SQL queries from the community will appear here once available.